During a recent cabinet meeting, Naftali Bennett, the Prime Minister of Israel, reportedly stated that Israel is looking into data on Pfizer's new corona medicine and the issue of securing its supplies for the nation’s population.
Meanwhile, the country’s Ministry of Health also announced that a decision on whether or not to approve the COVID-19 vaccination for children, aged between 5 to 11, will be unveiled on Wednesday.
Addressing the same, PM Bennett stated that there might be positive news concerning a cure for COVID-19. Over the weekend, the PM has asked the system to do an in-depth study of the purported new drug and ensure supply availability for the State of Israel. If the drug is allowed for usage, it will be another important tool in the fight against the pandemic, alongside immunizations for everyone and constant accessibility to testing.
Pfizer, which also makes the vaccination used in Israel, stated that its antiviral drug, Paxlovid, reduced the risk of hospitalization or death in persons at risk of major disease by 89%.
Albert Bourla, Pfizer’s CEO, stated that the business is in talks to supply the drug to 90 nations.
Despite earlier reports claiming that Israel was never one of the nations, Health Ministry Director-General, Prof. Nachman Ash, stated that although Jerusalem had not yet struck an agreement with the corporation, it is expected that deal would be announced in the coming days.
The ministry is currently debating if the vote should be held behind closed doors or open to the general public. On Thursday, the discussion was live-streamed.
Because of the high amount of verbal aggression around vaccines, Prof. Ash believes the ministry may choose not to expose the panel members in yet another public debate, as many of them work for non-governmental organizations and are not Health Ministry employees.
Meanwhile, Israel's mortality rate has been decreasing. Last week, only 194 new cases were reported, with 178 critical patients as of Sunday. Since Thursday last week, just two COVID-related deaths have been reported.